Stay updated on INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial

Sign up to get notified when there's something new on the INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has removed an erratum related to a previously cited article on non-motor features of Parkinson's disease.
    Difference
    0.4%
    Check dated 2025-05-07T19:11:44.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:51:25.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has undergone significant content changes, including the removal of detailed descriptions of a study on psilocybin therapy for depression and anxiety in Parkinson's disease, while retaining some structural elements like the study's location and assignment model.
    Difference
    20%
    Check dated 2025-04-16T01:47:17.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and changed a date from 2025-03-25 to 2025-01-01.
    Difference
    0.4%
    Check dated 2025-04-08T20:25:26.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-03-03T22:21:10.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:45:34.000Z thumbnail image

Stay in the know with updates to INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INO-4800 Safety/Tolerability/Immunogenicity in Healthy Volunteers Clinical Trial page.